人乳头瘤病毒引起的细胞转化：比较高危和低危病毒得出的经验教训。
Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.
机构信息
Department of Microbiology, University of Iowa, Iowa City, IA 52242, USA.
出版信息
Virology. 2012 Mar 15;424(2):77-98. doi: 10.1016/j.virol.2011.12.018. Epub 2012 Jan 27.
Abstract
The oncogenic potential of papillomaviruses (PVs) has been appreciated since the 1930s yet the mechanisms of virally-mediated cellular transformation are still being revealed. Reasons for this include: a) the oncoproteins are multifunctional, b) there is an ever-growing list of cellular interacting proteins, c) more than one cellular protein may bind to a given region of the oncoprotein, and d) there is only limited information on the proteins encoded by the corresponding non-oncogenic PVs. The perspective of this review will be to contrast the activities of the viral E6 and E7 proteins encoded by the oncogenic human PVs (termed high-risk HPVs) to those encoded by their non-oncogenic counterparts (termed low-risk HPVs) in an attempt to sort out viral life cycle-related functions from oncogenic functions. The review will emphasize lessons learned from the cell culture studies of the HPVs causing mucosal/genital tract cancers.
摘要
自 20 世纪 30 年代以来，人们已经认识到乳头瘤病毒（PV）的致癌潜力，但病毒介导的细胞转化机制仍在不断揭示。造成这种情况的原因包括：a）致癌蛋白具有多功能性，b）有越来越多的细胞相互作用蛋白，c）不止一种细胞蛋白可能与致癌蛋白的特定区域结合，d）对于相应非致癌 PV 编码的蛋白质，信息有限。本综述的观点将对比由致癌性人类乳头瘤病毒（称为高危 HPV）编码的病毒 E6 和 E7 蛋白与由非致癌性 HPV 编码的蛋白的活性（称为低危 HPV），试图将病毒生命周期相关功能与致癌功能区分开来。该综述将重点介绍从引起黏膜/生殖道癌症的 HPV 的细胞培养研究中获得的经验教训。
相似文献
1
Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.人乳头瘤病毒引起的细胞转化：比较高危和低危病毒得出的经验教训。
Virology. 2012 Mar 15;424(2):77-98. doi: 10.1016/j.virol.2011.12.018. Epub 2012 Jan 27.
2
The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation.人类乳头瘤病毒致癌蛋白：转化道路上靶向宿主通路的综述。
J Gen Virol. 2021 Mar;102(3). doi: 10.1099/jgv.0.001540. Epub 2021 Jan 11.
3
Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis.人乳头瘤病毒E6和E7癌蛋白作为肿瘤发生的危险因素。
J Biosci. 2009 Mar;34(1):113-23. doi: 10.1007/s12038-009-0013-7.
4
The human papillomavirus family and its role in carcinogenesis.人乳头瘤病毒家族及其在致癌作用中的角色。
Semin Cancer Biol. 2014 Jun;26:13-21. doi: 10.1016/j.semcancer.2013.11.002. Epub 2013 Dec 4.
5
Human papillomavirus immortalization and transformation functions.人乳头瘤病毒的永生化和转化功能。
Virus Res. 2002 Nov;89(2):213-28. doi: 10.1016/s0168-1702(02)00190-9.
6
Human Papillomaviruses-Associated Cancers: An Update of Current Knowledge.人乳头瘤病毒相关癌症：最新知识更新。
Viruses. 2021 Nov 6;13(11):2234. doi: 10.3390/v13112234.
7
Cancer associated human papillomaviruses.致癌型人乳头瘤病毒。
Curr Opin Virol. 2012 Aug;2(4):459-66. doi: 10.1016/j.coviro.2012.05.004. Epub 2012 Jun 2.
8
p53 degradation activity, expression, and subcellular localization of E6 proteins from 29 human papillomavirus genotypes.p53 降解活性、表达和 29 种人乳头瘤病毒基因型 E6 蛋白的亚细胞定位。
J Virol. 2012 Jan;86(1):94-107. doi: 10.1128/JVI.00751-11. Epub 2011 Oct 19.
9
Molecular interactions of 'high risk' human papillomaviruses E6 and E7 oncoproteins: implications for tumour progression.“高危型”人乳头瘤病毒E6和E7癌蛋白的分子相互作用：对肿瘤进展的影响
J Biosci. 2003 Apr;28(3):337-48. doi: 10.1007/BF02970152.
10
Papillomavirus E7 oncoproteins share functions with polyomavirus small T antigens.乳头瘤病毒E7癌蛋白与多瘤病毒小T抗原具有共同功能。
J Virol. 2015 Mar;89(5):2857-65. doi: 10.1128/JVI.03282-14. Epub 2014 Dec 24.
引用本文的文献
1
HPV16 E6 and E7 expressing cancer cells suppress the antitumor immune response by upregulating KLF2-mediated IL-23 expression in macrophages.表达人乳头瘤病毒16型E6和E7的癌细胞通过上调巨噬细胞中KLF2介导的白细胞介素-23表达来抑制抗肿瘤免疫反应。
J Immunother Cancer. 2025 Aug 19;13(8):e011915. doi: 10.1136/jitc-2025-011915.
2
NF-κB Activation Is Essential for Cervical Cell Proliferation and Malignant Transformation.核因子κB激活对于宫颈细胞增殖和恶性转化至关重要。
Int J Mol Sci. 2025 Mar 11;26(6):2493. doi: 10.3390/ijms26062493.
3
Augmented immunogenicity of the HPV16 DNA vaccine via dual adjuvant approach: integration of CpG ODN into plasmid backbone and co-administration with IL-28B gene adjuvant.通过双重佐剂方法增强HPV16 DNA疫苗的免疫原性：将CpG ODN整合到质粒骨架中并与IL-28B基因佐剂联合给药。
Virol J. 2025 Jan 8;22(1):3. doi: 10.1186/s12985-024-02604-7.
4
Viral Oncogenesis: Synergistic Role of Genome Integration and Persistence.病毒致癌作用：基因组整合与持续性的协同作用
Viruses. 2024 Dec 23;16(12):1965. doi: 10.3390/v16121965.
5
The Natural History of Cervical Cancer and the Case for MicroRNAs: Is Human Papillomavirus Infection the Whole Story?宫颈癌的自然史与微小RNA的情况：人乳头瘤病毒感染是全部原因吗？
Int J Mol Sci. 2024 Dec 3;25(23):12991. doi: 10.3390/ijms252312991.
6
Modulation of epithelial homeostasis by HPV using Notch and Wnt.人乳头瘤病毒利用Notch和Wnt信号通路调节上皮细胞稳态
Tumour Virus Res. 2024 Dec;18:200297. doi: 10.1016/j.tvr.2024.200297. Epub 2024 Nov 13.
7
The role of HR-HPV integration in the progression of premalignant lesions into different cancer types.高危型人乳头瘤病毒（HR-HPV）整合在癌前病变进展为不同癌症类型过程中的作用。
Heliyon. 2024 Jul 22;10(15):e34999. doi: 10.1016/j.heliyon.2024.e34999. eCollection 2024 Aug 15.
8
Preclinical Immunogenicity and Efficacy Studies for Therapeutic Vaccines for Human Papillomavirus-Type-16-Associated Cancer.人乳头瘤病毒16型相关癌症治疗性疫苗的临床前免疫原性和疗效研究
Vaccines (Basel). 2024 Jun 4;12(6):616. doi: 10.3390/vaccines12060616.
9
Multiomics analysis of metabolic heterogeneity in cervical cancer cell lines with or without HPV.对有人乳头瘤病毒（HPV）和无人乳头瘤病毒的宫颈癌细胞系代谢异质性的多组学分析。
Front Oncol. 2023 Nov 23;13:1194462. doi: 10.3389/fonc.2023.1194462. eCollection 2023.
10
Pioneer factors in viral infection.病毒感染的先驱因子。
Front Immunol. 2023 Oct 9;14:1286617. doi: 10.3389/fimmu.2023.1286617. eCollection 2023.
本文引用的文献
1
Beta-HPV 5 and 8 E6 promote p300 degradation by blocking AKT/p300 association.β-HPV5 和 8 E6 通过阻止 AKT/p300 结合促进 p300 的降解。
PLoS Pathog. 2011 Aug;7(8):e1002211. doi: 10.1371/journal.ppat.1002211. Epub 2011 Aug 25.
2
Disruption of repressive p130-DREAM complexes by human papillomavirus 16 E6/E7 oncoproteins is required for cell-cycle progression in cervical cancer cells.人乳头瘤病毒 16 型 E6/E7 癌蛋白破坏抑制性 p130-DREAM 复合物是宫颈癌细胞周期进展所必需的。
J Gen Virol. 2011 Nov;92(Pt 11):2620-2627. doi: 10.1099/vir.0.035352-0. Epub 2011 Aug 3.
3
Differential expression of cellular microRNAs in HPV 11, -16, and -45 transfected cells.HPV11、-16 和-45 转染细胞中细胞 microRNAs 的差异表达。
Biochem Biophys Res Commun. 2011 Aug 19;412(1):20-5. doi: 10.1016/j.bbrc.2011.07.011. Epub 2011 Jul 18.
4
Systematic analysis of the amino acid residues of human papillomavirus type 16 E7 conserved region 3 involved in dimerization and transformation.系统分析人乳头瘤病毒 16 型 E7 保守区 3 中参与二聚化和转化的氨基酸残基。
J Virol. 2011 Oct;85(19):10048-57. doi: 10.1128/JVI.00643-11. Epub 2011 Jul 20.
5
Human papillomavirus 16 E5 modulates the expression of host microRNAs.人乳头瘤病毒 16 E5 调节宿主 microRNAs 的表达。
PLoS One. 2011;6(7):e21646. doi: 10.1371/journal.pone.0021646. Epub 2011 Jul 1.
6
Suppression of STAT-1 expression by human papillomaviruses is necessary for differentiation-dependent genome amplification and plasmid maintenance.人乳头瘤病毒对 STAT-1 表达的抑制作用是分化依赖性基因组扩增和质粒维持所必需的。
J Virol. 2011 Sep;85(18):9486-94. doi: 10.1128/JVI.05007-11. Epub 2011 Jul 6.
7
NF-kappaB protects human papillomavirus type 38 E6/E7-immortalized human keratinocytes against tumor necrosis factor alpha and UV-mediated apoptosis.NF-κB 保护人乳头瘤病毒 38 型 E6/E7 永生化人角质形成细胞免受肿瘤坏死因子 α 和 UV 诱导的细胞凋亡。
J Virol. 2011 Sep;85(17):9013-22. doi: 10.1128/JVI.00002-11. Epub 2011 Jun 29.
8
The E7 open reading frame acts in cis and in trans to mediate differentiation-dependent activities in the human papillomavirus type 16 life cycle.E7 开放阅读框在顺式和反式作用中介导人乳头瘤病毒 16 型生命周期中分化依赖的活性。
J Virol. 2011 Sep;85(17):8852-62. doi: 10.1128/JVI.00664-11. Epub 2011 Jun 22.
9
Regulation of cellular miRNA expression by human papillomaviruses.人乳头瘤病毒对细胞微小RNA表达的调控
Biochim Biophys Acta. 2011 Nov-Dec;1809(11-12):668-77. doi: 10.1016/j.bbagrm.2011.05.005. Epub 2011 May 17.
10
The HPV-16 E7 oncoprotein induces centriole multiplication through deregulation of Polo-like kinase 4 expression.HPV-16 E7 癌蛋白通过调节 Polo 样激酶 4 的表达诱导中心体倍增。
Mol Cancer. 2011 May 24;10:61. doi: 10.1186/1476-4598-10-61.
Zotero 插件